Related Experiment Video
Updated: Oct 6, 2025

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
ALS2-Related Motor Neuron Diseases: From Symptoms to Molecules
Marcello Miceli1, Cécile Exertier2, Marco Cavaglià1
1PolitoBIOMedLab, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, 10129 Torino, Italy.
Abstract:
Infantile-onset Ascending Hereditary Spastic Paralysis, Juvenile Primary Lateral Sclerosis and Juvenile Amyotrophic Lateral Sclerosis are all motor neuron diseases related to mutations on the ALS2 gene, encoding for a 1657 amino acids protein named Alsin. This ~185 kDa multi-domain protein is ubiquitously expressed in various human tissues, mostly in the brain and the spinal cord. Several investigations have indicated how mutations within Alsin's structured domains may be responsible for the alteration of Alsin's native oligomerization state or Alsin's propensity to interact with protein partners. In this review paper, we propose a description of differences and similarities characterizing the above-mentioned ALS2-related rare neurodegenerative disorders, pointing attention to the effects of ALS2 mutation from molecule to organ and at the system level. Known cases were collected through a literature review and rationalized to deeply elucidate the neurodegenerative clinical outcomes as consequences of ALS2 mutations.
Related Concept Videos
Parkinson's Disease: Overview
Lysosomal Hydrolases
Cross-bridge Cycle
Neural Regulation
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate....
Satellite Stem Cells and Muscular Dystrophy

